Immunome inc.

Other-Pharmaceuticals

IMNM


Executive/
Director

Price

  • Last Close
  • $ 14.58
    $ -0.71 -4.64 %
    Dec 9, 2024
  • 52-Week High/Low
  • $27.34 - $6.35
  • YTD
  • 36.3%

  • Trading Volume
  • 26,526
  • Market Cap Full
  • $ 623M
  • Shares Outstanding
  • 42.7M
    Nov 7, 2023
2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Q1 - - - - - -5% 250% -56.2% 126.8% 130.7%
Q2 - - - - - 4% -48.9% -43.5% 58.5% -3.3%
Q3 - - - - - 8% 40.8% 38.3% 5.6% -
Q4 - - - - - -28% -46.8% -50.5% 30.5% -
J F M A M J J A S O N D
2024 54.9% 46.1% 2% -13.3% - - - - - - - -
2023 139.1% -13.1% 9.2% -3.8% 9.2% 51% -9.5% -9.9% 29.5% 5.4% -15.2% 43.4%
    2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
    0%0%0%0%0%0%0%34%-83%386%36%

Earnings

2020 2021 2022 2023
Q1 - -0.37 -0.96 -0.35
Q2 - -0.46 -0.74 -0.46
Q3 - -0.65 -0.75 -0.36
Q4 - -0.66 -0.64 -
A -5.3 -2.1 -3.1 -1.17

Annual Returns

52 Week
High/Low

Annual
Earnings

Chart

Trading Volume

2020 2021 2022 2023
Mar - 10.7 12.1 12.2
Jun - 11.8 12.1 12.2
Sep - 11.8 12.1 12.2
Dec 10.5 12.1 12.1 42.7

Financial Ratios

20222021202020192018
Asset Management
Inventory / Stock Turnover - - - - -
Fixed Asset Turnover - - - - -
Total Asset Turnover - - - - -
Leverage
Debt Ratio - - - - -
Debt – Equity Ratio - - - - -
Interest Coverage - - -2 - -
Equity multiplier 0.1 - 0.1 0.7 1